MEDIDEV: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIDEV
Largest movements
- Cash +€84,803
up €84,803 (+122%), from €69,547 to €154,350
mainly Net result for the year (+€65,312) and Receivables within one year (+€53,528)
- Receivables within one year -€53,528
down €53,528 (-97.9%), from €54,698 to €1,170
of which Trade receivables: -€54,698
- Deferred charges and accrued income +€38,522
up €38,522 (+2,139%), from €1,801 to €40,323
- Profit (loss) carried forward +€64,479
up €64,479 (+68.8%), from €93,719 to €158,199
- Other debts +€4,079
up €4,079 (+175%), from €2,336 to €6,415
- Tax, wage and social debts -€2,670
down €2,670 (-9.1%), from €29,252 to €26,583
- Trade debts +€2,605
up €2,605 (+2,410%), from €108 to €2,714
- Gross operating margin -€36,022
down €36,022 (-29.6%), from €121,533 to €85,511
- Taxes -€7,753
down €7,753 (-29.2%), from €26,583 to €18,830
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €129,416 | €197,974 | +€68,558 | +53.0% |
| Fixed assets | 21/28 | €3,369 | €2,131 | -€1,238 | -36.7% |
| Tangible fixed assets | 22/27 | €3,369 | €2,131 | -€1,238 | -36.7% |
| Furniture and vehicles | 24 | €3,369 | €2,131 | -€1,238 | -36.7% |
| Current assets | 29/58 | €126,046 | €195,843 | +€69,796 | +55.4% |
| Amounts receivable within one year | 40/41 | €54,698 | €1,170 | -€53,528 | -97.9% |
| Trade receivables | 40 | €54,698 | - | -€54,698 | |
| Other amounts receivable | 41 | - | €1,170 | +€1,170 | |
| Cash at bank and in hand | 54/58 | €69,547 | €154,350 | +€84,803 | +122% |
| Deferred charges and accrued income | 490/1 | €1,801 | €40,323 | +€38,522 | +2,139% |
| Total equity and liabilities | 10/49 | €129,416 | €197,974 | +€68,558 | +53.0% |
| Equity | 10/15 | €97,719 | €162,199 | +€64,479 | +66.0% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €93,719 | €158,199 | +€64,479 | +68.8% |
| Amounts payable | 17/49 | €31,696 | €35,776 | +€4,079 | +12.9% |
| Amounts payable within one year | 42/48 | €31,696 | €35,711 | +€4,015 | +12.7% |
| Trade debts | 44 | €108 | €2,714 | +€2,605 | +2,410% |
| Suppliers | 440/4 | €108 | €2,714 | +€2,605 | +2,410% |
| Taxes, remuneration and social security | 45 | €29,252 | €26,583 | -€2,670 | -9.1% |
| Taxes | 450/3 | €29,252 | €26,583 | -€2,670 | -9.1% |
| Other amounts payable | 47/48 | €2,336 | €6,415 | +€4,079 | +175% |
| Accrued charges and deferred income | 492/3 | - | €64 | +€64 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €345 | €1,238 | +€893 | +259% |
| Gross operating margin | 9900 | €121,533 | €85,511 | -€36,022 | -29.6% |
| Operating profit (loss) | 9901 | €121,189 | €84,273 | -€36,915 | -30.5% |
| Financial income | 75/76B | €0 | €0 | = | 0.0% |
| Recurring financial income | 75 | €0 | €0 | = | 0.0% |
| Financial charges | 65/66B | €54 | €131 | +€77 | +143% |
| Recurring financial charges | 65 | €54 | €131 | +€77 | +143% |
| Profit (loss) for the period before taxes | 9903 | €121,135 | €84,142 | -€36,993 | -30.5% |
| Income taxes | 67/77 | €26,583 | €18,830 | -€7,753 | -29.2% |
| Profit (loss) for the period | 9904 | €94,552 | €65,312 | -€29,240 | -30.9% |
| Profit (loss) for the period to be appropriated | 9905 | €94,552 | €65,312 | -€29,240 | -30.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.